MaxCyte, Inc. (MXCT) Q4 2025 Earnings Call Transcript

March 25, 2026 02:14:51 am

Source: SeekingAlpha

2026-03-25 02:14:51 ET

MaxCyte, Inc. (MXCT) Q4 2025 Earnings Call March 24, 2026 4:30 PM EDT

Company Participants

Eric Abdel
Maher Masoud - President, CEO & Executive Director
Douglas Swirsky - Chief Financial Officer
Sean Menarguez
...

For further details see:

MaxCyte Inc.

4.33% G/L:

$1.085 Last:

719,010 Volume:

$1.04 Open:

May 12, 2026 04:05:00 pm

April 29, 2026 04:05:00 pm

March 31, 2026 04:05:00 pm

March 24, 2026 05:49:40 pm

Market Cap $82,138,988

Float 103,153,769

Insiders Ownership 1.05%

Institutions 195

Short Percent N/A

Industry Biotechnology & Life Sciences

Sector Healthcare

Country US

City Rockville